|
1
|
Incekara F, Koene S, Vincent AJPE, van den
Bent MJ and Smits M: Association between supratotal glioblastoma
resection and patient survival: A systematic review and
meta-analysis. World Neurosurg. 127:617–624.e2. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verhaak RG, Hoadley KA, Purdom E, Wang V,
Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al:
Integrated genomic analysis identifies clinically relevant subtypes
of glioblastoma characterized by abnormalities in PDGFRA, IDH1,
EGFR, and NF1. Cancer Cell. 17:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma X, Shang F, Zhu W and Lin Q: CXCR4
expression varies significantly among different subtypes of
glioblastoma multiforme (GBM) and its low expression or
hypermethylation might predict favorable overall survival. Expert
Rev Neurother. 17:941–946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whitton B, Okamoto H, Packham G and Crabb
SJ: Vacuolar ATPase as a potential therapeutic target and mediator
of treatment resistance in cancer. Cancer Med. 7:3800–3811. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cotter K, Liberman R, Sun-Wada G, Wada Y,
Sgroi D, Naber S, Brown D, Breton S and Forgac M: The a3 isoform of
subunit a of the vacuolar ATPase localizes to the plasma membrane
of invasive breast tumor cells and is overexpressed in human breast
cancer. Oncotarget. 7:46142–46157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hinton A, Sennoune SR, Bond S, Fang M,
Reuveni M, Sahagian GG, Jay D, Martinez-Zaguilan R and Forgac M:
Function of a subunit isoforms of the V-ATPase in pH homeostasis
and in vitro invasion of MDA-MB231 human breast cancer cells. J
Biol Chem. 284:16400–16408. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McGuire C, Cotter K, Stransky L and Forgac
M: Regulation of V-ATPase assembly and function of V-ATPases in
tumor cell invasiveness. Biochim Biophys Acta. 1857:1213–1218.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishisho T, Hata K, Nakanishi M, Morita Y,
Sun-Wada GH, Wada Y, Yasui N and Yoneda T: The a3 isoform vacuolar
type H+-ATPase promotes distant metastasis in the mouse
B16 melanoma cells. Mol Cancer Res. 9:845–855. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang HD, Eun JW, Lee KB, Shen Q, Kim HS,
Kim SY, Seo DW, Park WS, Lee JY and Nam SW: T-cell immune regulator
1 enhances metastasis in hepatocellular carcinoma. Exp Mol Med.
50:e4202018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Colegio OR, Chu NQ, Szabo AL, Chu T,
Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC,
Phillips GM, et al: Functional polarization of tumour-associated
macrophages by tumour-derived lactic acid. Nature. 513:559–563.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chitirala P, Ravichandran K, Schirra C,
Chang HF, Krause E, Kazmaier U, Lauterbach MA and Rettig J: Role of
V-ATPase a3-subunit in mouse CTL function. J Immunol.
204:2818–2828. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Di Cristofori A, Ferrero S, Bertolini I,
Gaudioso G, Russo MV, Berno V, Vanini M, Locatelli M, Zavanone M,
Rampini P, et al: The vacuolar H+ ATPase is a novel therapeutic
target for glioblastoma. Oncotarget. 6:17514–17531. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Terrasi A, Bertolini I, Martelli C,
Gaudioso G, Di Cristofori A, Storaci AM, Formica M, Bosari S,
Caroli M, Ottobrini L, et al: Specific V-ATPase expression
sub-classifies IDHwt lower-grade gliomas and impacts glioma growth
in vivo. EBioMedicine. 41:214–224. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li B, Severson E, Pignon JC, Zhao H, Li T,
Novak J, Jiang P, Shen H, Aster JC, Rodig S, et al: Comprehensive
analyses of tumor immunity: Implications for cancer immunotherapy.
Genome Biol. 17:1742016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gravendeel LA, Kouwenhoven MC, Gevaert O,
de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB,
Kloosterhof NK, et al: Intrinsic gene expression profiles of
gliomas are a better predictor of survival than histology. Caner
Res. 69:9065–9072. 2009. View Article : Google Scholar
|
|
17
|
Bowman RL, Wang Q, Carro A, Verhaak RG and
Squatrito M: GlioVis data portal for visualization and analysis of
brain tumor expression datasets. Neuro Oncol. 19:139–141. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang ZL, Li GZ, Wang QW, Bao ZS, Wang Z,
Zhang CB and Jiang T: PD-L2 expression is correlated with the
molecular and clinical features of glioma, and acts as an
unfavorable prognostic factor. Oncoimmunology. 8:e15415352019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshihara K, Shahmoradgoli M, Martinez E,
Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jia D, Li S, Li D, Xue H, Yang D and Liu
Y: Mining TCGA database for genes of prognostic value in
glioblastoma microenvironment. Aging (Albany NY). 10:592–605. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Ou DH, Zhuang DW, Zheng ZF and
Lin ME: In silico analysis of the immune microenvironment in
bladder cancer. BMC Cancer. 20:2652020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren Q, Zhu P, Zhang H, Ye T, Liu D, Gong Z
and Xia X: Identification and validation of stromal-tumor
microenvironment-based subtypes tightly associated with PD-1/PD-L1
immunotherapy and outcomes in patients with gastric cancer. Cancer
Cell Int. 20:922020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang C, Cheng W, Ren X, Wang Z, Liu X, Li
G, Han S, Jiang T and Wu A: Tumor purity as an underlying key
factor in glioma. Clin Cancer Res. 23:6279–6291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen B, Lai J, Dai D, Chen R, Li X and
Liao N: JAK1 as a prognostic marker and its correlation with immune
infiltrates in breast cancer. Aging (Albany NY). 11:11124–11135.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi S, Ye S, Mao J, Ru Y, Lu Y, Wu X, Xu
M, Zhu T, Wang Y, Chen Y, et al: CMA1 is potent prognostic marker
and associates with immune infiltration in gastric cancer.
Autoimmunity. 53:210–217. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan Q, Sun N, Zheng J, Wang Y, Yan X, Mai
W, Liao Y and Chen X: Prognostic and Immunological Role of FUN14
domain containing 1 in pan-cancer: Friend or foe? Front Oncol.
9:15022019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rizvi NA, Mazieres J, Planchard D,
Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E,
Mennecier B, et al: Activity and safety of nivolumab, an anti-PD-1
immune checkpoint inhibitor, for patients with advanced, refractory
squamous non-small-cell lung cancer (CheckMate 063): A phase 2,
single-arm trial. Lancet Oncol. 16:257–265. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hodi FS, O'Day SJ, McDermott DF, Weber RW,
Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel
JC, et al: Improved survival with ipilimumab in patients with
metastatic melanoma. N Engl J Med. 363:711–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sennoune SR, Bakunts K, Martinez GM,
Chua-Tuan JL, Kebir Y, Attaya MN and Martinez-Zaguilan R: Vacuolar
H+-ATPase in human breast cancer cells with distinct metastatic
potential: Distribution and functional activity. Am J Physiol Cell
Physiol. 286:C1443–C1452. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gleize V, Boisselier B, Marie Y,
Poea-Guyon S, Sanson M and Morel N: The renal v-ATPase a4 subunit
is expressed in specific subtypes of human gliomas. Glia.
60:1004–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Razavi SM, Lee KE, Jin BE, Aujla PS,
Gholamin S and Li G: Immune evasion strategies of glioblastoma.
Front Surg. 3:112016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Katara GK, Jaiswal MK, Kulshrestha A,
Kolli B, Gilman-Sachs A and Beaman KD: Tumor-associated vacuolar
ATPase subunit promotes tumorigenic characteristics in macrophages.
Oncogene. 33:5649–5654. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Trombetta ES, Ebersold M, Garrett W,
Pypaert M and Mellman I: Activation of lysosomal function during
dendritic cell maturation. Science. 299:1400–1403. 2003. View Article : Google Scholar : PubMed/NCBI
|
